Development of a core evaluation framework of value-added medicines: report 2 on pharmaceutical policy perspectives

BACKGROUND: A core evaluation framework that captures the health care and societal benefits of value added medicines (VAMs, also often called repurposed medicines) was proposed in Report 1, aiming to reduce the heterogeneity in value assessment processes across countries and to create incentives for...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Cost Eff Resour Alloc
Autors principals: Kaló, Zoltán, Petykó, Zsuzsanna Ida, Fricke, Frank-Ulrich, Maniadakis, Nikos, Tesař, Tomáš, Podrazilová, Kateřina, Espin, Jaime, Inotai, András
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2021
Matèries:
Review
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC8280561/
https://ncbi.nlm.nih.gov/pubmed/34266465
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12962-021-00296-2
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars